Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice (Q39618107)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 December 2010

Language	Label	Description	Also known as
English	Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice	scientific article published on 18 December 2010

Statements

scholarly article

1 reference

Europe PubMed Central

13 September 2017

Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice (English)

1 reference

Europe PubMed Central

13 September 2017

lung metastasis

1 reference

based on heuristic

inferred from title

author name string

Eun Ji Kim

1

1 reference

Europe PubMed Central

13 September 2017

Ji Eun Hong

2

1 reference

Europe PubMed Central

13 September 2017

Soon Ju Eom

3

1 reference

Europe PubMed Central

13 September 2017

Jae-Yong Lee

4

1 reference

Europe PubMed Central

13 September 2017

Jung Han Yoon Park

5

1 reference

Europe PubMed Central

13 September 2017

language of work or name

0 references

publication date

18 December 2010

1 reference

Europe PubMed Central

13 September 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

13 September 2017

130

1 reference

Europe PubMed Central

13 September 2017

1

1 reference

Europe PubMed Central

13 September 2017

61-71

1 reference

Europe PubMed Central

13 September 2017

https://scigraph.springernature.com/pub.10.1007/s10549-010-1299-8

0 references

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Managing treatment side effects in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Involvement of the mitochondrial death pathway in chemopreventive benzyl isothiocyanate-induced apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Requirement of a carbon spacer in benzyl isothiocyanate-mediated cytotoxicity and MAPK activation in head and neck squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Cell cycle arrest, apoptosis induction and inhibition of nuclear factor kappa B activation in anti-proliferative activity of benzyl isothiocyanate against human pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

A link between benzyl isothiocyanate-induced cell cycle arrest and apoptosis: involvement of mitogen-activated protein kinases in the Bcl-2 phosphorylation

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Benzyl isothiocyanate-induced apoptosis in human breast cancer cells is initiated by reactive oxygen species and regulated by Bax and Bak.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Benzyl isothiocyanate targets mitochondrial respiratory chain to trigger reactive oxygen species-dependent apoptosis in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Benzyl isothiocyanate inhibits metalloproteinase-2/-9 expression by suppressing the mitogen-activated protein kinase in SK-Hep1 human hepatoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Benzyl isothiocyanate (BITC) inhibits migration and invasion of human colon cancer HT29 cells by inhibiting matrix metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Inhibitory effects of benzyl isothiocyanate and benzyl thiocyanate on diethylnitrosamine-induced hepatocarcinogenesis in rats

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Prevention of mammary carcinogenesis in MMTV-neu mice by cruciferous vegetable constituent benzyl isothiocyanate

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Nontransgenic models of breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Oral administration of 3,3'-diindolylmethane inhibits lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

The effect of the bisphosphonate ibandronate on breast cancer metastasis to visceral organs

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Matrix metalloproteinases and the development of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

The plasminogen-plasmin system in malignancy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Preclinical development of metalloproteasis inhibitors in cancer therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Tissue inhibitors of metalloproteinases: evolution, structure and function

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Novel functions of TIMPs in cell signaling

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Clinical relevance of serum levels of matrix metallopeptidase-2, and tissue inhibitor of metalloproteinase-1 and -2 in patients with malignant melanoma.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Tumor metastasis: mechanistic insights and clinical challenges

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1299-8

21 January 2018

Identifiers

10.1007/S10549-010-1299-8

1 reference

Europe PubMed Central

13 September 2017

1 reference

Europe PubMed Central

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39618107&oldid=1846092756"